Changing interpretation of human health risks from perfluorinated compounds

Public Health Reports

Volumn 129, Issue 6, 2014, Pages 482-485

  Clapp, Richard ^b,c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; PERFLUORO COMPOUND; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; FLUOROCARBON;

ADVERSE DRUG REACTION; ARTICLE; CANCER RISK; CARCINOGENICITY; CHRONIC TOXICITY; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HUMAN; IMMUNOTOXICITY; KIDNEY CANCER; LEYDIG CELL TUMOR; LIVER CELL CARCINOMA; LIVER TOXICITY; NONHODGKIN LYMPHOMA; NONHUMAN; OVARY CANCER; PANCREAS TUMOR; PROSTATE CANCER; PUBLIC HEALTH; TESTIS CANCER; BLOOD; HISTORY; NUTRITION; RISK ASSESSMENT; TOXICITY; TRENDS; UNITED STATES;

ENVIRONMENTAL EXPOSURE; FLUOROCARBONS; HISTORY, 20TH CENTURY; HUMANS; NUTRITION SURVEYS; PUBLIC HEALTH; RISK ASSESSMENT; UNITED STATES;

EID: 84908235893     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491412900605     Document Type: Article

References (32)

1. Lindstrom AB, Strynar MJ, Libelo EL. Polyfluorinated compounds: past, present, and future. Environ Sci Technol 2011;45:7954-61.
2. Environmental Protection Agency (US). Provisional health advisories for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). Washington: EPA; 2009.
3. Sargent JW, Seffl RJ. Properties of perfluorinated liquids. Fed Proc 1970;29:1699-703.
4. Taves DR. Evidence that there are two forms of fluoride in human serum. Nature 1968;217:1050-1.
5. Ubel FA, Sorenson SD, Roach DE. Health status of plant workers exposed to fluorochemicals-a preliminary report. Am Ind Hyg Assoc J 1980;41:584-9.
6. Olsen GW, Gilliland FD, Burlew MM, Burris JM, Mandel JS, Mandel JH. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 1998;40:614-22.
7. Griffith FD, Long JE. Animal toxicity studies with ammonium perfluorooctanoate. Am Ind Hyg Assoc J 1980;41:576-83.
8. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Tully JS, Needham LL. Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES). Environ Sci Technol 2007;41:2237-42.
9. Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ Sci Technol 2011;45:8037-45.
10. Kato K, Calafat AM, Wong LY, Wanigatunga AA, Caudill SP, Needham LL. Polyfluoroalkyl compounds in pooled sera from children participating in the National Health and Nutrition Examination Survey 2001-2002. Environ Sci Technol 2009;43:2641-7.
11. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007;115:1298-305.
12. Alexander BH, Olsen GW. Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers. Ann Epidemiol 2007;17:471-8.
13. Leonard RC, Kreckmann KH, Sakr CJ, Symons JM. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 2008;18:15-22.
14. Lundin JI, Alexander BH, Olsen GW, Church TR. Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 2009;20:921-8.
15. Steenland K, Woskie S. Cohort mortality study of workers exposed to perfluorooctanoic acid. Am J Epidemiol 2012;176:909-17.
16. Vieira VM, Hoffman K, Shin HM, Weinberg JM, Webster TF, Fletcher T. Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis. Environ Health Perspect 2013;121:318-23.
17. Steenland K, Fletcher T, Savitz DA. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 2010;118:1100-8.
18. Post GB, Cohn PD, Cooper KR. Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature. Environ Res 2012;116:93-117.
19. Svoboda DJ, Azarnoff DL. Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug. Cancer Res 1979;39:3419-28.
20. Cook JC, Murray SM, Frame SR, Hurtt ME. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. Toxicol Appl Pharmacol 1992;113:209-17.
21. Environmental Protection Agency (US), Science Advisory Board. SAB review of EPA's draft risk assessment of potential human health effects associated with PFOA and its salts. Washington: EPA; 2006.
22. Goldenthal EI, Jessup DC, Geil RG, Jefferson ND, Arceo RJ, Ruecker FA. Final report: ninety day subacute rat toxicity study on Fluorad® fluorochemical, FC-143. International Research and Development Corporation, Study No. 137- 089, 3M Reference No. T-3141, November 6, 1978, U.S. EPA Administrative Record, AR226-0441.
23. Butenhoff J, Costa G, Elcombe C, Farrar D, Hansen K, Iwai H, et al. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 2002;69:244-57.
24. Corsini E, Sangiovanni E, Avogadro A, Galbiati V, Viviani B, Marinovich M, et al. In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Toxicol Appl Pharmacol 2012;258:248-55.
25. Grandjean P, Andersen EW, Budtz-Jorgensen E, Nielsen F, Molbak K, Weihe P, et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds [published erratum appears in JAMA 2012;307:1142]. JAMA 2012;307:391-7.
26. Fei C, McLaughlin JK, Lipworth L, Olsen J. Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood. Environ Res 2010;110:773-7.
27. Granum B, Haug LS, Namork E, Stolevik SB, Thomsen C, Aaberge IS, et al. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol 2013;10:373-9.
28. White SS, Fenton SE, Hines EP. Endocrine disrupting properties of perfluorooctanoic acid. J Steroid Biochem Mol Biol 2011;127:16-26.
29. Grandjean P, Budtz-Jorgensen E. Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children. Environ Health 2013;12:35.
30. Sass J. The chemical industry delay game: how the chemical industry ducks regulation of the most toxic substances. Washington: Natural Resources Defense Council; 2011.
31. National Research Council. Science and decisions: advancing risk assessment. Washington: National Academies Press; 2009.
32. Grandjean P. Science for precautionary decision-making. In: Gee D, Grandjean P, Hansen SF, van den Hove S, MacGarvin M, Martin J, et al., editors. Late lessons from early warnings: science, precaution, innovation. Copenhagen: European Environment Agency; 2013. p. 623-42.